Global, Regional, and National Burden of Atopic Dermatitis: Insights From the Global Burden of Disease Study 2021
Dermatitis® · 06.08.2025
DOI: 10.1177/17103568251365559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatitis®, online erschienen am 06.08.2025. Verfasst von Huan Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: From the Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Jiangsu Province Hospital of Chinese Medicine Foundation, Project 333 of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The 2017 Global Burden of Disease (GBD) report identified atopic dermatitis (AD) as the skin disease with the highest disease burden, assessed in terms of disability-adjusted life-years (DALYs), and a modest increase in the number of AD-associated DALYs was observed in 2019 compared to 2017.
Objective
This study aims to provide updated insights from the GBD 2021 database.
Methods
Data on the prevalence and DALYs of AD in 2021 were extracted from the GBD database. Statistical analyses were performed by R software (version 4.4.1).
Results
In 2021, AD still represented the highest age-standardized DALY rate (ASDR) among all skin disorders. Globally, the age-standardized prevalence rate (ASPR) and ASDR of AD were 1728.5 (95% UI: 1658.5–1798.6) and 75.5 (95% UI: 38.8–125.6) per 100,000 population, respectively. The ASPR and ASDR were highest in high-income Asia Pacific but lowest in Central Sub-Saharan Africa. The burden of AD was mainly in children, declining with age; however, a modest rise in ASPR and ASDR was noted among the elderly. Women generally experienced a higher burden than men.
Conclusions
In 2021, AD remained the leading cause of DALYs among skin diseases, disproportionately affecting children and older adults, especially in urban areas.
Autor:innen und Institutionen
- From the Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
ORCID-Profile: Huan Liu, Hongmin Li
Förderung
- Jiangsu Province Hospital of Chinese Medicine Foundation
- Project 333 of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Liu, H., Dong, H., Chen, W., Li, X., Xiao, Z., & Li, H. (2025). Global, Regional, and National Burden of Atopic Dermatitis: Insights From the Global Burden of Disease Study 2021. Dermatitis®. https://doi.org/10.1177/17103568251365559
Vancouver
Liu H, Dong H, Chen W, Li X, Xiao Z, Li H. Global, Regional, and National Burden of Atopic Dermatitis: Insights From the Global Burden of Disease Study 2021. Dermatitis®. 2025. doi:10.1177/17103568251365559
BibTeX
@article{Liu2025,
author = {Liu, Huan and Dong, Hanyue and Chen, Wei and Li, Xinxin and Xiao, Ziyi and Li, Hongmin},
title = {Global, Regional, and National Burden of Atopic Dermatitis: Insights From the Global Burden of Disease Study 2021},
journal = {Dermatitis®},
year = {2025},
doi = {10.1177/17103568251365559}
}
EUVIMED